Semnur Pharmaceuticals, Inc. Interest Expense
Semnur Pharmaceuticals, Inc. (SMNR) reported Interest Expense of $28.34 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-08-15
- Semnur Pharmaceuticals, Inc. interest expense for the quarter ending 2025-06-30 was $28.34K, a 22.92% increase year-over-year.
- Semnur Pharmaceuticals, Inc. interest expense for the quarter ending 2025-03-31 was $26.97K, a 26.62% increase year-over-year.
- Semnur Pharmaceuticals, Inc. interest expense for the quarter ending 2024-06-30 was $23.06K.
- Semnur Pharmaceuticals, Inc. interest expense for the quarter ending 2024-03-31 was $21.30K.
- Semnur Pharmaceuticals, Inc. interest expense for fiscal 2024 was $96.24K, a 160.75% increase from fiscal 2023.
- Semnur Pharmaceuticals, Inc. interest expense for fiscal 2023 was $36.91K.
| Period end | Interest Expense | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $28.34K 10-Q · filed 2025-08-15 | $55.32K 10-Q · filed 2025-08-15 | |||
| 2025-03-31 | $26.97K 10-Q · filed 2025-05-16 | ||||
| 2024-12-31 | $96.24K 10-K · filed 2025-04-02 | ||||
| 2024-06-30 | $23.06K 10-Q · filed 2025-08-15 | $44.36K 10-Q · filed 2025-08-15 | $62.07K derived: sum of 3 quarters · filed 2025-08-15 | $76.81K derived: sum of 4 quarters · filed 2025-08-15 | |
| 2024-03-31 | $21.30K 10-Q · filed 2025-05-16 | $39.02K derived: sum of 2 quarters · filed 2025-05-16 | $53.75K derived: sum of 3 quarters · filed 2025-05-16 | ||
| 2023-12-31 | $17.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $32.45K derived: sum of 2 quarters · filed 2025-04-02 | $36.91K 10-K · filed 2025-04-02 | ||
| 2023-10-11 | $100.00K 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $14.74K 10-Q · filed 2023-11-09 | $19.20K 10-Q · filed 2023-11-09 |